Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Cantor Fitzgerald
Julphar
Queensland Health
Cipla
Johnson and Johnson
Daiichi Sankyo
Dow
Baxter

Generated: May 24, 2018

DrugPatentWatch Database Preview

FLURBIPROFEN SODIUM Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Flurbiprofen Sodium patents expire, and what generic alternatives are available?

Flurbiprofen Sodium is a drug marketed by Bausch And Lomb and is included in one NDA.

The generic ingredient in FLURBIPROFEN SODIUM is flurbiprofen sodium. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the flurbiprofen sodium profile page.
Drug patent expirations by year for FLURBIPROFEN SODIUM
Pharmacology for FLURBIPROFEN SODIUM
Synonyms for FLURBIPROFEN SODIUM
(1,1'-Biphenyl)-4-acetic acid, 2-fluoro-alpha-methyl-, sodium salt
2-Fluoro-alpha-methyl-4-diphenylacetic acid sodium salt
56767-76-1
8308AB
AF10211
AN-40130
AUAGTGKMTMVIKN-UHFFFAOYSA-M
C15H12FNaO2
CHEMBL1200990
EINECS 260-373-2
Flurbiprofen sodium [USAN]
Flurbiprofen sodium [USP]
Flurbiprofen sodium salt
KB-51899
LS-44096
Ocufen
RL04144
SCHEMBL4735171
sodium 2-(2-fluorobiphenyl-4-yl)propanoate
sodium 2-(3-fluoro-4-phenyl-phenyl)propanoate
Sodium 2-fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetate
Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate
Sodium 2-fluoro-alpha-methyl[1,1'-biphenyl]-4-acetate
Sodium 3-fluoro-4-phenylhydratropate
Sodium flurbiprofen
Sodiumflurbiprofen

US Patents and Regulatory Information for FLURBIPROFEN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb FLURBIPROFEN SODIUM flurbiprofen sodium SOLUTION/DROPS;OPHTHALMIC 074447-001 Jan 4, 1995 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Covington
Cerilliant
McKesson
Teva
UBS
Fuji
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.